Cancer Immunology

GPTKB entity

Statements (62)
Predicate Object
gptkbp:instanceOf scientific research
gptkbp:aimsTo develop new cancer treatments
understand tumor-immune interactions
gptkbp:focusesOn immune system response to cancer
gptkbp:hasApplication biomedical research
drug development
clinical oncology
gptkbp:hasConcept gptkb:natural_killer_cells
gptkb:CTLA-4
gptkb:T_cells
gptkb:regulatory_T_cells
gptkb:PD-1
cytokines
immune checkpoint blockade
inflammation
dendritic cells
macrophages
antigen presentation
PD-L1
immune response modulation
immune modulation
immune escape
adoptive cell transfer
tumor antigens
cancer metastasis
immune tolerance
tumor progression
immune memory
immune system activation
immune cell infiltration
tumor-infiltrating lymphocytes
immune suppression
tumor immunogenicity
immune biomarkers
immune cell exhaustion
immune checkpoint molecules
immune checkpoint therapy
immune checkpoints
immune escape mechanisms
immunoediting
immunogenic cell death
immunosurveillance
immunotherapeutic agents
immunotherapy resistance
myeloid-derived suppressor cells
neoantigens
tumor immune microenvironment
tumor-associated macrophages
tumor-specific antigens
https://www.w3.org/2000/01/rdf-schema#label Cancer Immunology
gptkbp:includes immunotherapy
gene therapy
monoclonal antibodies
cancer vaccines
checkpoint inhibitors
gptkbp:relatedTo immunology
oncology
gptkbp:studies tumor microenvironment
immune surveillance
immune evasion by tumors
gptkbp:bfsParent gptkb:Mount_Sinai_Endowed_Professor_in_Cancer_Immunology
gptkbp:bfsLayer 7